Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan in Uterine Fibroids (ASTEROID 2)
NCT02465814Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 2 trial of vilaprisan in Uterine Fibroids (UF), sponsored by Bayer. Started Jun 2015; status: completed.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02465814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465814.